 "pharma")
Aurobindo Pharma shares slipped 8 per cent to Rs 579 on the BSE in early morning trade on Friday after the company received a warning letter from US health regulator for its Unit XI, API (Active Pharmaceutical Ingredients) manufacturing facility in Srikakulam, Andhra Pradesh.
The stock was trading close to its 52-week low of Rs 566 touched on July 19, 2018 on the BSE in intra-day trade.
The company said the action follows the earlier inspection of the site by the USFDA (United States Food and Drug Administration) agency in February 2019.
“The Company has received a
The stock was trading close to its 52-week low of Rs 566 touched on July 19, 2018 on the BSE in intra-day trade.
The company said the action follows the earlier inspection of the site by the USFDA (United States Food and Drug Administration) agency in February 2019.
“The Company has received a
